Vimarsana
Biggest News Aggregation in the World

Page 11 - National Immunization Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from National Immunization Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In National Immunization Program Today - Breaking & Trending Today

Global Adult Vaccine Market 2023: Rapid Growth in India with Increasing Awareness and Healthcare Measures - Vimarsana News

Global Adult Vaccine Market 2023: Rapid Growth in India with Increasing Awareness and Healthcare Measures

/PRNewswire/ -- The "Adult Vaccines Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report...

Indonesia targets 2030 hepatitis B, C elimination - Vimarsana News

Indonesia targets 2030 hepatitis B, C elimination

Indonesia is targeting to eliminate hepatitis B and C by 2030 through several interventions that will involve community participation, said Imran Pambudi, ...

GC Biopharma's "GC FLU" obtains vaccine approval in Egypt: First-ever approval of the company's quadrivalent flu vaccine on the African continent - Vimarsana News

GC Biopharma's "GC FLU" obtains vaccine approval in Egypt: First-ever approval of the company's quadrivalent flu vaccine on the African continent

/PRNewswire/ -- GC Biopharma, a South Korean biopharmaceutical company, announced on the 18th that its quadrivalent flu vaccine called GC FLU Quadrivalent...

GSK, Green Cross, Kwang Dong fined for rigging vaccine prices - Vimarsana News

GSK, Green Cross, Kwang Dong fined for rigging vaccine prices

A total of 32 local and global vaccine manufacturers, distributors and retail sellers were fined a combined 40.9 billion won ($32.1 million) for rigging bid prices of vaccines, the country's antitrust agency said Thursday. Included are global multinational pharma titan GlaxoSmithKline and its local peers ― Kwangdong Pharmaceutical, GC Biopharma, SK Discovery, Yuhan and Korea Vaccine Sales.

Diagnosis of Viral Hepatitis Is Still a Major Challenge - Vimarsana News

Diagnosis of Viral Hepatitis Is Still a Major Challenge

World Hepatitis Day is an opportunity to remind people of the impact of viral hepatitis and to offer information that can help prevent, diagnose, and treat these diseases, said one expert.